nanomolar HIV-1 maturation inhibitor

interesting structure

derivative of GSK3532795/BMS955176

Bioorg. Med. Chem. Lett., Jan. 26, 2021

Bristol Myers Squibb, CT + NJ

Chemical structure of compound 16 BMS HIV-1 maturation inhibitor

The BMS HIV-1 maturation inhibitor, “compound 16,” is a potent derivative of the clinical candidate GSK3532795/955176, with double-digit nanomolar activity in cells. The spiro[3.3]hept-5-ene effectively replaces a phenyl ring…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: